| | | | | | | |

Lung Disease Stigma May Impact Mesothelioma Outcomes

depressionPatients with non-communicable respiratory diseases (NCRDs) such as mesothelioma, lung cancer and asthma may feel stigmatized by their illness and those feelings can impact their clinical outcomes.

That is the message of a report from researchers in New South Wales, Australia, a country with one of the highest per capita rates of malignant mesothelioma in the world.

Experts in public health and behavioral science at the University of Newcastle performed an extensive review of the medical literature for evidence of stigma-related experiences and their potential impact on outcomes in mesothelioma patients and others with NCRDs.

Although they found that the risks of stigma-related experiences were low to moderate in this population (and most prevalent in those with lung cancer), they found that those who did feel stigmatized tended to have worse outcomes.

The Stigma of Respiratory Disease

People with respiratory diseases like pleural mesothelioma may experience or perceive a stigma against them for a number of reasons.

Former smokers who develop lung cancer may suffer psychologically because of their own or the public’s perception that they are responsible for their cancer. People with asthma may be embarrassed by the need to use an inhaler in public.

Since mesothelioma has virtually only one cause – exposure to asbestosmesothelioma patients may feel the stigma of having been “victimized” by an employer who failed to warn or protect them. If a mesothelioma patient was warned about the danger of asbestos but failed to use adequate protective equipment, he or she may also experience feelings of guilt or shame.

According to the authors of “Stigma-related experiences in non-communicable respiratory diseases”, shame, blame, guilt and stigma have all been shown to negatively impact survival.

“It is therefore important for clinicians to…identify potential patient stigma or related experiences to understand and appropriately discuss concerns sensitively to alleviate the impact,” writes researcher and lead author Shiho Rose.

Emotional Impact of Mesothelioma Still Not Well-Documented

One study included in the Australian review found that people with lung cancer who were also depressed were less likely to follow their treatment plan and, as a result, had worse outcomes.

Although Rose and her colleagues did find some studies pointing to the stigma and associated emotional impact of pleural mesothelioma and other lung diseases, they say more rigorous research on the subject is needed.

“Evidence suggests that patients with a range of NCRDs report feelings of perceived stigma, shame, blame or guilt,” states the report. “However, a comprehensive and current review of the data regarding stigma-related experiences and their broader impacts on a range of respiratory diseases is lacking.”

A separate study conducted in the UK in December 2016 found that “psychological distress”, including feelings of stigma, blame and guilt, is “historically high” in patients with mesothelioma and can impact their care experience.

Source:

Rose, S, et al, “Stigma-related experiences in non-communicable respiratory diseases”, Jan 2017, Chronic Respiratory Disease, Epub ahead of print

Ball, H, “A systematic literature review comparing the psychological care needs of patients with mesothelioma and advanced lung cancer”, December 2016, European Journal of Oncology Nursing, pp 62-67

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…